Jul 16, 2008
Dicerna Pharmaceuticals, a Second Generation RNA Interference...
Dicerna Pharmaceuticals, Inc. , an RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology , today announced a second closing of its Series A financing, receiving ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
